Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and treatment regimens for these patients.
❄️ Give the Gift of Answers, Support, and Hope ❄️
Please make a donation to the Aplastic Anemia and MDS International Foundation this holiday season.